Benefits
VO2 max and endurance improvement
Senactiv supplementation increased VO2 max time-to-exhaustion by 20% in a human HIIT cycling trial. Athletes sustained effort 20% longer and produced 20% more total work output vs. placebo — a performance improvement large enough to meaningfully impact competitive results.
Glycogen resynthesis acceleration
After a 60-minute cycling bout at 70% VO2 max, Senactiv supplementation increased muscle glycogen resynthesis rates by 370% (2.73x) over the 3 hours post-exercise vs. placebo. Faster glycogen restoration means faster recovery and ability to train again sooner.
Citrate synthase and ATP production
Muscle biopsies from Senactiv subjects showed 47% more citrate synthase enzyme activity — the rate-limiting enzyme of the Krebs cycle and the primary determinant of aerobic ATP production capacity. More citrate synthase means more efficient energy generation during sustained effort.
Senescent cell clearance
In a HIIT cycling study, 9 of 12 Senactiv subjects showed complete elimination of senescent muscle cells (marked by β-galactosidase) after exercise — vs. no change in placebo. Clearing old dysfunctional cells allows healthier, more mitochondria-rich new cells to populate muscle tissue.
Mechanism of action
Ginsenoside Rg1 anti-inflammatory and mitochondrial signaling
The ginsenoside Rg1 from Panax notoginseng reduces exercise-induced inflammatory signaling in skeletal muscle (TNF-α, IL-6, lipid peroxidation), while simultaneously promoting citrate synthase expression and mitochondrial biogenesis — improving the energy production efficiency of active muscle tissue.
Insulin receptor and GLUT4 preservation during exercise
Intense exercise disrupts insulin receptor and GLUT4 transporter function in muscle membranes, slowing glucose uptake and glycogen replenishment. Senactiv preserves GLUT4 expression and insulin receptor integrity during HIIT, maintaining the glucose supply pipeline for faster glycogen restoration post-exercise.
Senolytic clearance of β-galactosidase-positive cells
Senactiv activates macrophage infiltration of exercised muscle tissue, which selectively identifies and removes senescent cells marked by β-galactosidase accumulation. This cellular 'housekeeping' effect allows muscle stem cells to generate fresh, high-performance muscle cells in their place.
Clinical trials
Randomized, double-blind, placebo-controlled crossover study in healthy young men performing HIIT cycling. Outcomes: VO2 max, time to exhaustion, citrate synthase activity in muscle biopsy. (Yeh et al. 2014; or related)
Young healthy male HIIT cyclists.
Senactiv® group showed ~20% longer time-to-exhaustion at VO2 max, ~47% higher citrate synthase activity in muscle biopsy. Industry-funded (NuLiv Science). Effect sizes substantial — warrants independent replication.
Randomized, double-blind, placebo-controlled crossover study examining senolytic effects of Senactiv® in 12 young men performing HIIT cycling, with muscle biopsy analysis. Note: full peer-reviewed publication may be limited.
12 healthy young men (mean age 21). Randomized, double-blind, placebo-controlled crossover; 5 mg purified Rg1 (active in Senactiv®) or placebo 1 hour before high-intensity cycling at 70% VO₂max. Vastus lateralis biopsies pre- and post-exercise. Separate 12-pt arm tested cycling time-to-exhaustion.
9 of 12 Rg1 participants showed complete elimination of senescence-associated β-galactosidase (SA-β-gal) signals in exercised muscle vs no change in placebo (p<0.05). Cycling time-to-exhaustion at 80% VO₂max increased ~20% with Rg1. First human evidence of senolytic activity in exercising muscle.